The National Electronic Disease Surveillance System (NEDSS) Territories Annual Reporting

The National Electronic Disease Surveillance System (NEDSS)

ATT- 1D TB Notification Message Mapping Guide 06052007.xls

The National Electronic Disease Surveillance System (NEDSS) Territories Annual Reporting

OMB: 0920-0728

Document [xlsx]
Download: xlsx | pdf

Overview

ATT-1D
Introduction
Revisions
Key
Subject-related
Generic Obs.
TB Observations
Notification Structure

Sheet 1: ATT-1D
Attachment 1D.

TB Notification Message

Mapping Guide 06052007.xls

Sheet 2: Introduction
TB Notification Message Mapping Guide
















VERSION: The version of this Message Mapping Guide is Draft 0.6 dated 6/5/2007.







This Message Mapping Guide describes the content and message mapping specifications for the fixed set of data elements used to communicate information to meet the requirements for TB Individual Case reporting to CDC. The intended audience for this document are the state/local and CDC programs and other public health related organizations interested in using the HL7 V2.5 case notification message specification for transmitting their data elements.









References







Version 1.0 of the Message Specification Guide is used to inform the mapping methodology for this guide.
Notify CDC Message–All PAMs from NEDSS PAM Platform Team. Last updated 1/26/2007.







NEDSS PAM Platform Help Guide, 11/30/2006.
















Understanding the Organization of the Mapping Guide







Revisions This tab is intended to provide revision control for updates made to the document.






Key Key to columns in each Tab/Worksheet






Subject-related This tab provides the mapping methodology for the demographic variables requested by the program.
Generic Obs. This tab provides the content for the generic investigation questions (observations). The ones that are not used for this particular instance are greyed out.
TB Observations This tab provides the investigation/case-related content requested by the program for this specific notification.
Notification Structure This tab provides the structural elements for the Notification. These variables are not negotiable. Default values are provided for HL7 structural elements that are required but not part of the surveillance data requested.


















Variables as Observations







Other than the variables that map to the Patient Identifier segment (see Subject-Specific tab), all other variables are passed as a series of OBX-Observation/Result segments that are logically tied to the OBR-Observation Request “section header” segment that immediately precedes it. This content presents the real differences between the messages since all types of Notifications are handled in a standard manner up to this point.

Sheet 3: Revisions
Revisions




Date Version Description
4/20/2007 Draft v. 0.5 Added "notification subject type" to the Notification Structural Data to bring the message structure in line with the Outbreak Management version of the ORU Case Investigation Report message.
4/20/2007 Draft v. 0.5 Changed all observations that use the CE value type in OBX-2 to CWE - coded with exception - to prepare for versioning of value sets. The additional fields are still optional at this point.
4/24/2007 Draft v. 0.5 Added "patient name type" to the Notification Structural data to account for the default value that must be provided in the message.
4/24/2007 Draft v. 0.5 Remapped NTF139 to NOT108 for use as the PHIN Variable ID used for MSH-10 Message Control ID (UID nor text appears in this context)
5/3/2007 Draft v. 0.5 Removed NOT110 Record Type variable. This observation is no longer necessary as the Notification Type specified in NOT101 contains this information.
6/5/2007 Draft v. 0.6 Created a Generic Observations tab and greyed out any generic surveillance questions that TB does not use. Only the TB-specific observations remain on the TB Observations tab.

Sheet 4: Key
Key to columns in each Tab/Worksheet:







Column Description
Program Variables Section
PHIN Variable ID PHIN element UID drawn from the coding system PH_PHINQuestions_CDC
Label Short name for the data element, which is passed in the message.
Description Description of the data element as in PHIN Questions.
Data Type Data type for the variable response expected by the program area
Prog. Req/Opt Indicator whether the program specifies the field as:
R - Required - mandatory for sending the message
O - Optional - if the data is available it should be passed
Coded Concepts Concepts that the program uses in answer to a particular question that required a coded response.
May Repeat Indicator whether the response to the data element may repeat. “Yes” in the field indicates that it may; otherwise, the field is not populated. Repeats require special processing.
Data Validation Business rules used for validating data integrity
Value Set Name Name of the pre-coordinated value set from which the response is drawn. The value sets and coding systems are accessible via the Public Health Information Network Vocabulary Access and Distribution Services at http://www.cdc.gov/PhinVSBrowser/StrutsController.do.
Message Mapping Methodology Section
Message Context Specific HL7 segment and field mapping for the element.
HL7 Data Type HL7 data type used by PHIN to express the variable.
HL7 Usage Use of the field for PHIN. Indicates if the field is required, optional, or conditional in a segment. The only values that appear in the Message Mapping are:
• R – Required. Must always be populated
• O – Optional. May optionally be populated.
HL7 Cardinality Indicator of the minimum and maximum number of times the element may appear.
• [0..0] Element never present.
• [0..1] Element may be omitted and it can have at most, one Occurrence.
• [1..1] Element must have exactly one Occurrence.
• [0..n] Element may be omitted or may repeat up to n times.
• [1..n] Element must appear at least once, and may repeat up to n times.
• [0..*] Element may be omitted or repeat for an unlimited number of times.
• [1..*] Element must appear at least once, and may repeat unlimited number of times.
• [m..n] Element must appear at least m, and at most, n times.
Implementation Notes Related implementation comments.

Sheet 5: Subject-related
Subject/Demographic Variables
Mapping Methodology
PHIN Variable ID Label/Short Name Description Data Type CDC Req/Opt May Repeat Coded Concepts Value Set Name Data Validation
Message Context HL7 Data Type HL7 Usage HL7 Cardinality Implementation Notes
DEM197 Local patient ID The local ID of the patient/entity. Text R




PID-3 Patient Identifier List (does not pass Variable ID or label) CX R [1..1] Only the sending system's internally assigned patient id used for these de-identified messages
DEM115 Birth Date Reported date of birth of patient. Date O




PID-7 Date/Time of Birth (does not pass Variable ID or label) TS O [0..1]
DEM113 Patient’s sex Patient’s current sex. Code O
Male
Female
Unknown		 Sex (MFU)

PID-8 Administrative Sex (does not pass Variable ID or label) IS O [0..1]
DEM152 Race Category Field containing one or more codes that broadly refer to the patient’s race(s). Code O Y Native Hawaiian or Other Pacific Islander
American Indian or Alaska Native
Asian
White
Black or African American
Other Race		 Race Category

PID-10 Race (does not pass Variable ID or label) CE O [0..*]
DEM153 Detailed Race A patient record may have zero, one, or multiple detailed race categories assigned. Code O Y
Detailed Race

Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. To keep the race category in context with detailed races, pass the race category in the first instance of this field and the detailed race codes as repeats. If more than one race category was passed in PID-10 Race, use a second OBX Detailed Race segment instance to keep that grouping in context. CWE O [0..*]
DEM155 Ethnic Group Code Ethnic origin or ethnicity is based on the individual’s self-identity of the patient as Hispanic or Latino; choose one value from the list. Code O
Hispanic
Non-hispanic		 Ethnicity Group

PID-22 Ethnic Group (does not pass Variable ID or label) CE O [0..1]
DEM156 Detailed Ethnicity If the value specified in Ethnicity is Hispanic or Latino, choose detailed ethnicity value(s) that better define the patient's Latino ethnicity; values may include Cuban, Mexican, etc.; choose one or multiple values from this list. This variable is not passed unless specified for the particular condition. Code O Y
Detailed Ethnicity

Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. CWE
[0..*]
DEM2003 US Citizen Is the patient a US citizen? Boolean O
True
False


Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. IS O [0..1] Used IS datatype to pass only T or F
DEM2004 Nationality What is the patients country of origin? Code O

Country

Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. CWE O [0..1]
DEM2005 Date of Entry into US Date arrived in U.S. from another country. Date O




Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. TS O [0..1]

Sheet 6: Generic Obs.
The generic surveillance elements that are not used for TB are shaded.













Generic Surveillance Variables
Mapping Methodology
PHIN Variable ID Label/Short Name Description Data Type CDC Req/Opt May Repeat Valid Concepts Value Set Name Data Validation
Message Context HL7 Data Type HL7 Usage HL7 Cardinality Implementation Notes
NOT109 Reporting State State reporting the notification. Code R
2 char alpha state codes State

Observation/OBX Segment with this UID and label CWE O [0..1]
NOT113 Reporting County County reporting the notification. Code R

County

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV169 Condition Code Condition or event that constitutes the reason the notification is being sent. Coded R

zvx6: Subset specific to STD Nationally Notifiable Infectious Disease (NND) must be 10220 Tuberculosis
(note that this is a Notification structural element, so it appears twice in this Guide) CE O [0..1]
INV168 Record ID System-assigned local ID of the investigation with which the case subject/entity is associated. (NOTE for TB: this is the RVCT ID). Text R

zvx6: Subset specific to STD


OBR-3.1 Filler Order Number (does not pass Variable ID or label) EI R [0..1]
INV172 Local Case ID Official local (city/county) identification number for the case Text O




Observation/OBX Segment with this UID and label ST O [0..1]
INV173 State Case ID Official state identification number for the case; used by the state and the CDC to identify the case in communications. Text R




Observation/OBX Segment with this UID and label ST O [0..1]
INV107 Jurisdiction Code Identifier for the physical site from which the notification is being submitted. Code R
state-assigned jurisdiction codes


Observation/OBX Segment with this variable ID and label IS O [0..1]
INV108 Case Program Area Code The organizational ownership of the investigation. Program areas (e.g., Immunization, STD) are defined at the state level by the conditions for which they provide primary prevention and control. Code O
state-assigned


Observation/OBX Segment with this variable ID and label IS O [0..1]
INV109 Case Investigation Status Code Status of the investigation. For example, open or closed. Code O
Open
Closed


Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV2006 Case Close Date Date the case investigation status was marked as Closed. Date O


If the user enters the Date Closed for a case then the date must be >= Date Opened
Observation/OBX Segment with this variable ID and label TS O [0..1]
INV110 Investigation Date Assigned Date the investigator was assigned to this investigation. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV111 Date of Report Date the event or illness was first reported by the reporting source. Date R


Validate that the Report date is more than 12 months after previous TB year; Validate that the Report date is equal to or after Patient Date of Birth; Validate that the Report date is equal to or after Date Entered US; Validate that the Report Date must be equal to or before Count date;
Observation/OBX Segment with this UID and label TS O [0..1]
INV112 Reporting Source Type Code Type of facility or provider associated with the source of information sent to Public Health. Code O

Reporting Source Type NND

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV114 Reporting Source Name Name of the provider reporting the case (typically the patient's primary care provider) Text O




Observation/OBX Segment with this variable ID and label ST O [0..1]
INV115a Reporting Source Address Line 1 Reporting source street address Line 1 Text O




Observation/OBX Segment with this variable ID and label ST O [0..1]
INV115b Reporting Source Address Line 2 Reporting source street address Line 2 Text O




Observation/OBX Segment with this variable ID and label ST O [0..1]
INV116 Reporting Source Address City Reporting source address city Code O

City

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV117 Reporting Source Address State Reporting source address state Code O

State

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV118 Reporting Source Zip Code Zip Code of the reporting source for this case. Alphanumeric O




Observation/OBX Segment with this variable ID and label ST O [0..1]
INV119 Reporting Source Address County Reporting source address county Code O

County

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV120 Earliest Date Reported to County Earliest date reported to county public health system Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV121 Earliest Date Reported to State Earliest date reported to state public health system Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV128 Hospitalized Was patient hospitalized because of this event? Code O
Yes
No
Unknown		 Yes No Unknown (YNU) 1) If the patient was hospitalized for this illness, then enable entry of admission date
2) If the patient was hospitalized for this illness, then enable entry of discharge date
3) If the patient was hospitalized for this illness, then enable entry of total duration of stay in the hospital in days
4) If the patient was hospitalized for this illness, then enable entry of hospital information
Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV129 Hospital Name Name of the healthcare faciility in which the subject was hospitalized. Text O




Observation/OBX Segment with this variable ID and label ST O [0..1]
INV132 Admission Date Subject’s admission date to the hospital for the condition covered by the investigation. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV133 Discharge Date Subject's discharge date from the hospital for the condition covered by the investigation. Date O


If the user enters the Discharge Date, then the date must be >= Admission Date
Observation/OBX Segment with this variable ID and label TS O [0..1]
INV134 Duration of hospital stay in days Subject's duration of stay at the hospital for the condition covered by the investigation. Numeric O




Observation/OBX Segment with this variable ID and label SN O [0..1]
INV136 Diagnosis Date Date of diagnosis of condition being reported to public health system Date O


1) If the user enters the Diagnosis Date, then the date must be >= Illness Onset Date
2) If the user enters the Diagnosis Date, then the date must be >= Rash Onset Date
Observation/OBX Segment with this variable ID and label TS O [0..1]
INV137 Date of Illness Onset Date of the beginning of the illness. Reported date of the onset of symptoms of the condition being reported to the public health system Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV138 Illness End Date Time at which the disease or condition ends. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV139 Illness Duration Length of time this person had this disease or condition. Numeric O




Observation/OBX Segment with this variable ID and label SN O [0..1]
INV140 Illness Duration Units Unit of time used to describe the length of the illness or condition. Code O

Duration Unit (UCUM)

Observation/OBX Segment with this variable ID and label CE O [0..1]
INV143 Illness Onset Age Age at onset of illness Numeric O




Observation/OBX Segment with this variable ID and label SN O [0..1]
INV144 Illness Onset Age Units Age units at onset of illness Code O
Days
Months
Weeks
Years		 Age Unit

uses INV143 observation - maps to OBX-6-Units (does not use INV144 ID or label) CWE O [0..1]
INV145 Did the patient die from this illness Did the patient die from this illness or complications of this illness? Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV146 Date of death The date and time the subject’s death occurred. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV147 Investigation Start Date The date the case investigation was initiated. Date O




Observation/OBX Segment with this UID and label TS O [0..1]
INV150 Case outbreak indicator Denotes whether the reported case was associated with an identified outbreak. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) If this case is part of an outbreak of 5 or more cases, then enable entry of outbreak name (INV151)
Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV151 Case Outbreak Name A state-assigned name for an indentified outbreak. Code O
state-assigned code


Observation/OBX Segment with this variable ID and label IS O [0..1]
INV152 Case Disease Imported Code Indication of where the disease/condition was likely acquired. Code

Indigenous;Out of country;Out of jurisdiction;Out of state;Unknown Disease Acquired Jurisdiction

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV153 Imported Country If the disease or condition was imported, indicates the country in which the disease was likely acquired. Code O

Country

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV154 Imported State If the disease or condition was imported, indicates the state in which the disease was likely acquired. Code O

State

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV155 Imported City If the disease or condition was imported, indicates the city in which the disease was likely acquired. Code O

City

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV156 Imported County If the disease or condition was imported, contains the county of origin of the disease or condition. Code O

County

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV157 Transmission Mode Code for the mechanism by which disease or condition was acquired by the subject of the investigation. Includes sexually transmitted, airborne, bloodborne, vectorborne, foodborne, zoonotic, nosocomial, mechanical, dermal, congenital, environmental exposure, indeterminate. Code O

Case Transmission Mode

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV159 Detection Method Code for the method by which the public health department was made aware of the case. Includes provider report, patient self-referral, laboratory report, case or outbreak investigation, contact investigation, active surveillance, routine physical, prenatal testing, perinatal testing, prison entry screening, occupational disease surveillance, medical record review, etc. Code O

Case Detection Method

Observation/OBX Segment with this variable ID and label CWE O [0..1] Note required by program
INV161 Confirmation Method Code for the mechanism by which the case was classified, providing information about how the case classification status was derived. More than one confirmation method may be indicated. Code O Y
Case Confirmation Method

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV162 Confirmation Date If an investigation is confirmed as a case, the confirmation date is entered. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV163 Case Class Status Code Status of the case/event as suspect, probable, confirmed, or "not a case" per CSTE/CDC/ surveillance case definitions. Code R
Confirmed
Not a Case
Probable
Suspect 		Case Class Status

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV165 MMWR Week MMWR Week for which case information is to be counted for MMWR publication. Numeric R


IF the MMWR date has already been specified previously THEN Do Not allow the user to specify the MMWR date again.; If MMWRDATE has a date THEN date must not be greater than or equal to reportdate;
Observation/OBX Segment with this UID and label SN O [0..1]
INV166 MMWR Year MMWR Year (YYYY) for which case information is to be counted for MMWR publication. Date R


IF The MMWR date has already been specified previously THEN Do Not allow the user to specify the MMWR date again.; If MMWRDATE has a date THEN date must not be greater than or equal to reportdate;
Observation/OBX Segment with this UID and label TS O [0..1]
INV176 Date of First Report to CDC Date the case was first reported to the CDC. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV177 Date First Reported PHD Earliest date the case was reported to a public health department. Date O




Observation/OBX Segment with this variable ID and label TS O [0..1]
INV178 Pregnancy status Indicates whether the patient was pregnant at the time of the event. Code

YNU Yes No Unknown (YNU)

Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV179 PID Indicates whether or not the patient has pelvic inflammatory disease (PID). Code


Only valid for female patients. Yes No Unknown (YNU)
Observation/OBX Segment with this variable ID and label CWE O [0..1]
INV2001 Age at case investigation Patient age at time of case investigation Numeric O


age units required
Observation/OBX Segment with this variable ID and label SN O [0..1]
INV2002 Age units at case investigation Patient age units at time of case investigation Code O
Days
Months
Weeks
Years		 Age Unit

uses the INV2001 observation - maps to OBX-6-Units (does not use INV2002 ID or label) CWE O [0..1]

Sheet 7: TB Observations
TB Case Notification variables.





Program-Specific Surveillance Variables
Mapping Methodology
PHIN Variable ID Label/Short Name Description Data Type CDC Req/Opt May Repeat Coded Concepts Value Set Name Data Validation
Message Context HL7 Data Type HL7 Usage HL7 Cardinality Implementation Notes
TB098 Investigation Submitted By Name of the person who should be contacted if there are questions regarding the data in the report (typically the person submitting the report). Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB203 RVCT Status Indicate the current status of the RVCT (such as open, rejected, or closed); possible values: Approved - indicates the RVCT was reviewed by a reviewer and approved; the record appears as an alert in the worklist of a supervisor to be forwarded to the CDC and/or closed; Closed - indicates the RVCT is complete and no longer active; Deleted - deletes the record; users with the delete privilege granted by security template make this status setting to delete the RVCT record; Notified - indicates that the RVCT record was submitted to the CDC; supervisor users with the appropriate security privilege make this setting, which causes the record to be transmitted to the CDC; Opened - initial state of an RVCT record; the RVCT has been created, but not yet completed; Ready for Review - indicates the RVCT is ready for review by a reviewer; changing status to this value causes the record to appear as an alert in the worklist of a reviewer; Rejected - indicates the RVCT was reviewed by a reviewer and found to be incomplete or incorrect; the record appears as an alert in the worklist of the data entry user who owns the RVCT; Suspended - indicates that the record is temporarily inactive; used to prevent a record from being included in reports without closing and re-opening the record. Code R
Approved
Notified
Closed
Deleted
Opened
Ready for Review		 Case Investigation Status IF the user changes the status of the RVCT to 'Approved' THEN enable the entry of the 'Do you want to count this patient
at the CDC as a verified case of TB?' question value.; IF the user changes the status of the RVCT to 'Approved' THEN enable the entry of the Approval Comments.; IF the user changes the status of the RVCT to 'Rejected' THEN enable the entry of the Rejection Comments; IF the user changes the status of the RVCT to 'Deleted' THEN enable the entry of the Rejection Comments; IF the status of an RVCT is 'Closed' THEN the status cannot be changed to 'Deleted.'; IF the RVCT has a status = 'Closed' or 'Deleted' THEN the status of the RVCT cannot be changed to 'Suspend.'
Observation/OBX Segment with this UID and label CWE O [0..1]
TB080 Reporting Address City City name associated with the address, zip code, and state values. Text O

City

Observation/OBX Segment with this UID and label CWE O [0..1]
TB099 Inside City Limits Indicate whether or not the address is within city limits; choose Unknown if it is not known for sure whether it is. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) Yes No Unknown (YNU)
Observation/OBX Segment with this UID and label CWE O [0..1]
TB081 Reporting Address County Reporting address county. Code O
county FIPS codes County

Observation/OBX Segment with this UID and label CWE O [0..1]
TB082 Reporting Address Zip Code Reporting address Zip Code. Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB100 Date Counted If a value of Yes is specified for Do you want to count this patient at the CDC as a verified case of TB?, then enter the month and year for which the case is to be counted. Date R


Validate that the Count date is equal to or after Patient Date of Birth; Validate that the Count date is equal to or after Date Entered US; Validate that the Count date is equal to or after Report date; Validate that the Count date is more than 12 months after previous TB year;
Observation/OBX Segment with this UID and label TS O [0..1]
TB199 Legacy Client ID Legacy Client ID. This field may be used to pass a patient identifier from a legacy system being converted to the new TB format. Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB200 Legacy RVCT ID Legacy RVCT ID. This field may be used to pass a TB Case identifier from a legacy system being converted to the new TB format. Text O




Observation/OBX Segment ST O [0..0]
TB202 Estimated US Entry Date Indicator Date the patient entered the US if the patient was not US-born or not born overseas to US parents (e.g., born on a military base); outlying US areas (e.g., Puerto Rico, Guam, Virgin Islands) are not considered part of the United States and they should be listed as separate countries. Boolean O




Observation/OBX Segment with this UID and label IS O [0..1]
TB101 Status at Diagnosis of TB Status of the patient at the time tuberculosis was diagnosed (alive, dead, or unknown). Code O
Alive
Dead
Unknown		 General Condition Status

Observation/OBX Segment with this UID and label CWE O [0..1]
TB102 Previous Diagnosis of TB Indicates whether the patient had a previous diagnosis of tuberculosis; choose Yes if the patient had a verified case of the disease in the past, had been discharged (completed therapy), or was lost to supervision for more than 12 consecutive months, and has the disease again. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB103 Year of Previous Diagnosis If a value of Yes was specified for Previous Diagnosis of TB, indicate the year in which the previous episode was diagnosed (use the format YYYY); if there were multiple previous episodes, then this is the year for the last such episode. Date O


Validate that the Patient Date of Birth is equal to or before Previous TB diagnosis year
Observation/OBX Segment with this UID and label TS O [0..1]
TB104 More than One Previous Episode More than one previous episode. Boolean O




Observation/OBX Segment with this UID and label IS O [0..1]
TB105 Major Site of Disease Major site of disease; choose one item from the list. Code O
Lymphatic Other
Lymphatic Unknown
Eye and ear appendages
Miliary
Site not Stated
Fetus and embryo
Liver structure
Bone and joint
Epiglottis and larynx
Jejunum and ileum
Middle ear AND mastoid cells
Placenta, umbilical cord and implantation site
Paranasal sinus part
Meninges structure
Brain structure
Bone marrow structure
Pancreatic structure
Extrahepatic duct structure
Cardiac valve structure
Entire duodenum
Entire mouth region
Urogenital structure
Tongue structure
Adrenal structure
Nervous system structure
Spinal cord structure
Intrathoracic lymphatic structure
Gallbladder structure
Thyroid and/or parathyroid structures
Tonsil and adenoid structure
Pleural structure
Esophageal structure
Rectum structure
All teeth, gums and supporting structures
Salivary gland structure
Lung structure
Skin structure
Tracheal structure
Nasal structure
Lip structure
Anal structure
Pharyngeal structure
Pituitary structure
Blood vessel structure
Appendix structure
Stomach structure
Nasopharyngeal structure
Colon structure
Subcutaneous tissue structure
Breast structure
Pericardial structure
Splenic structure
Heart structure
Cervical lymph node structure
Peritoneal cavity structure
Blood
Thymus gland structure		 Major Site of Disease (TB) Validate that the Major Site has a value then must not be the same value as additional site; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Sputum Culture; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Micro Exam Sites 1 and 2
Observation/OBX Segment with this UID and label CWE O [0..1]
TB106 Additional Site of Disease Additional sites affected; do not make choices in this list if Miliary was specified in Major Site of Disease. Code O Y Lymphatic Other
Lymphatic Unknown
Eye and ear appendages
Miliary
Fetus and embryo
Liver structure
Bone and joint, CS
Epiglottis and larynx, CS
Jejunum and ileum, CS
Middle ear AND mastoid cells
Placenta, umbilical cord and implantation site
Paranasal sinus part
Meninges structure
Brain structure
Bone marrow structure
Pancreatic structure
Extrahepatic duct structure
Cardiac valve structure
Entire duodenum
Entire mouth region
Urogenital structure
Tongue structure
Adrenal structure
Nervous system structure
Spinal cord structure
Intrathoracic lymphatic structure
Gallbladder structure
Thyroid and/or parathyroid structures
Tonsil and adenoid structure
Pleural structure
Esophageal structure
Rectum structure
All teeth, gums and supporting structures
Salivary gland structure
Lung structure
Skin structure
Tracheal structure
Nasal structure
Lip structure
Anal structure
Pharyngeal structure
Pituitary structure
Blood vessel structure
Appendix structure
Stomach structure
Nasopharyngeal structure
Colon structure
Subcutaneous tissue structure
Breast structure
Pericardial structure
Splenic structure
Heart structure
Cervical lymph node structure
Peritoneal cavity structure
Blood
Thymus gland structure		 Additional Site of Disease (TB) Validate that the Major Site has a value then must not be the same value as additional site; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Sputum Culture; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Micro Exam Sites 1 and 2
Observation/OBX Segment with this UID and label CWE O [0..*]
TB107 More than One Additional Site More than one additional site indicator. This is a derived field: If Additional Site of Disease has a value, set = TRUE. Boolean O




Observation/OBX Segment with this UID and label IS O [0..1]
TB108 Sputum Smear Results of a sputum smear; choose Positive if any one examination is positive for acid-fast organisms; choose Negative if the results of all or the only examination were negative; choose Not Done if a sputum smear is known to have not been done; choose Unknown if it is not known whether a sputum smear was performed (or if the results are not known for reasons other than the results are pending). Code O
Positive
Negative
Not Done
Unknown		 Positive Negative Unknown Not Done

Observation/OBX Segment with this UID and label CWE O [0..1]
TB109 Sputum Culture Results of a sputum culture; choose Positive if any one examination is positive for M. tuberculosis complex (if the culture grows organisms other than M. tuberculosis, M. bovis, or M. africanum, then choose Negative); choose Negative if the results were negative for M. tuberculosis complex; choose Not Done if a sputum culture is known to have not been done; choose Unknown if it is not known whether a sputum culture was performed (or if the results are not known for reasons other than the results are pending). Code O
Positive
Negative
Not Done
Unknown		 Positive Negative Unknown Not Done Validate that if Sputum Culture OR CULTURE equals 'Positive' then enable Initial Susceptibility test; IF (Q18) SPUTUM CULTURE equals "Positive" then enable (Q35A) SPUTUM CULTURE CONVERSION.;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB110 Microscopic Exam of Tissue and Other Body Fluids Results of a microscopic exam (non-sputum); choose Positive if any tissue or fluid other than sputum was positive for acid-fast organisms; choose Negative if all microscopic exams were negative for acid-fast organisms; choose Not Done if exams were known to have not been performed; choose Unknown if it is not known whether microscopic exams were performed (or if the results are not known for reasons other than the results are pending). Code O
Positive
Negative
Not Done
Unknown		 Positive Negative Unknown Not Done If Microscopic Exam equals Positive, THEN enable Microscopic First Site;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB111 Microscopic Exam Site 1 If a value of Positive is specified for Microscopic Exam of Tissue and Other Body Fluids, choose the appropriate site; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease and additional site(s) of the disease. Code O
Eye and ear appendages
Skeletal system (bones of head, rib cage, and vertebral column)
Meninges, dural sinus, choroid plexus
Skeletal system (bones of shoulder, girdle, pelvis, and extremities
Other
Soft tissue (muscles of head, neck, mouth and upper extremity
Soft tissue (muscles of trunk, perineum, and lower extremity
Multiple Sites
Omentum and peritoneum
CSF (cerebrospinal fluid)
Fallopian tube, broad ligament, parametrium, and paraovarian region
Ovary
Female genital fluids
Placenta, umbilical cord, and implantation site
Pituitary gland
Adrenal gland
Ear and mastoid cells
Thymus
Pus
Brain
Spinal cord
Cranial, spinal and peripheral nerve
Lung
Myometrium
Thyroid or parathyroid gland(s)
Cardiac valve
Liver
Bronchus
Bronchiole
Pleura
Upper respiratory fluids
Bronchial fluid
Pleural fluid
Epiglottis and larynx
Heart
Nasopharynx
Pericardial fluid
Blood vessel
Mouth
Lip
Tongue
Tooth, gum and supporting structures of the tooth
Salivary gland
Pericardium
Lymph node
Kidney
Endometrium
Skin and skin appendages
Subcutaneous tissue
Breast
Milk
Bone marrow
Trachea
Blood
Soft tissue (not otherwise specified)
Bone (not otherwise specified)
Tendon and tendon sheath
Ligament and fascia
Joints (synovial tissue)
Synovial fluid
Nose
Accessory sinus
Spleen
Testis
Gastric aspirate
Gastrointestinal contents (feces)
Peritoneal fluid
Renal pelvis
Ureter
Urinary bladder
Urethra
Anus
Prostate and seminal vesicle
Urine
Epididymis, vas deferens, spermatic cord and scrotum
Male genital fluids
Vulva, labia, clitoris, and Bartholin's gland
Cervix
Uterus
Gallbladder
Vagina
Penis
Rectum
Small intestine - duodenum
Small intestine - jejunum & ileum
Esophagus
Tonsils and adenoids
Appendix
Stomach
Saliva
Pharynx, oropharynx, and hypopharynx
Pancreas
Extrahepatic bile duct
Colon
Bile and pancreatic fluid
Fetus and embryo		 Microscopic Exam Culture Site (TB) Validate that the Microscopic first site has a value then must not be the same value as Microscopic second site; If Microscopic First Site has a value, THEN enable Microscopic Second Site
Observation/OBX Segment with this UID and label CWE O [0..1]
TB112 Microscopic Exam Site 2 If a value of Positive is specified for Microscopic Exam of Tissue and Other Body Fluids, choose the appropriate site if a second site is applicable; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease and additional site(s) of the disease. Code O
<see TB111> Microscopic Exam Culture Site (TB) Validate that the Microscopic first site has a value then must not be the same value as Microscopic second site;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB113 Culture of Tissue and Other Body Fluids Results of a culture of tissue or bodily fluid (non-sputum); choose Positive if any tissue or fluid other than sputum was positive for M. tuberculosis complex; choose Negative if all cultures were negative; choose Not Done if the cultures were known to have not been performed; choose Unknown if it is not known whether the cultures were performed (or if the results are not known for reasons other than the results are pending). Code O
Positive
Negative
Not Done
Unknown		 Positive Negative Unknown Not Done Validate that if Other Culture equals 'Positive' then enable Other culture first site;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB114 Culture Site 1 If a value of Positive is specified for Culture of Tissue and Other Body Fluids, choose the appropriate site; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease, and additional site(s) of the disease. Code O
<see TB111> Microscopic Exam Culture Site (TB) Validate that the Other Culture first site has a value then must not be the same value as Other culture second site;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB115 Culture Site 2 If a value of Positive is specified for Culture of Tissue and Other Body Fluids, choose the appropriate site if a second site is applicable. The values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease, and additional site(s) of the disease. Code O
<see TB111> Microscopic Exam Culture Site (TB) Validate that the Other Culture first site has a value then must not be the same value as Other culture second site
Observation/OBX Segment with this UID and label CWE O [0..1]
TB116 Chest X-ray Results Results of a chest x-ray; choose Abnormal if the results indicate; choose Not Done if the x-rays were known to have not been done; choose Unknown if it is not known whether the x-rays were done (or if the results are unknown). Code O
Abnormal
Normal
Unknown
Not done		 Chest XRay Result Validate that if X-Ray equals 'Abnormal' then enable X-Ray abnormality, X-Ray status;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB117 Abnormal Chest X-ray Cavitary Status If a value of Abnormal is specified in Chest X-Ray, then indicate whether any of the x-rays done at any time during this episode of tuberculosis showed a cavity or cavities, was noncavitary consistent with tuberculosis, or was noncavitary inconsistent with tuberculosis. Code O
Cavity
Noncavitary consistent w TB
Noncavitary not consistent w TB
Unknown		 Abnormal Chest XRay Finding (TB)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB118 Abnormal Chest X-ray Condition Status If a value of Abnormal is specified in Chest X-Ray, then indicate if a series of x-rays show the disease to be stable, worsening, or improving (do not update this information through the course of the patient's follow-up; use the indication at the time of the report). Code O
Improving
Stable
Unknown
Worsening
 Abnormal Chest X-ray Condition Status

Observation/OBX Segment with this UID and label CWE O [0..1]
TB119 Skin Test at Diagnosis Results of a skin test (Mantoux - tuberculin, PPD, STU); choose Positive if the patient is probably infected with M. tuberculosis; choose Negative if the skin test did not meet the current criteria for a positive test; choose Not Done if the skin test was known to have not been performed; choose Unknown if it is not known whether the skin test was performed (or if the results are not known). Code O
Positive
Negative
Not Done
Unknown		 Positive Negative Unknown Not Done

Observation/OBX Segment with this UID and label CWE O [0..1]
TB120 Millimeters of Induration If a value of Positive is specified in Skin Test at Diagnosis, indicate the millimeters of induration (if the result only indicates that the result was positive but does not specify induration, specify 99 here); Numeric O




Observation/OBX Segment with this UID and label SN O [0..1]
TB121 Was Patient Anergic If a value of Negative is specified in Skin Test at Diagnosis, indicate whether or not the patient was known to be anergic (i.e., the patient shows no immune response due to being immunocompromised) Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB122 HIV Status Indicate the patient's HIV status; choose Indeterminate if the patient has had a documented indeterminate HIV antibody test within the past year before the tuberculosis diagnosis; choose Negative if the patient has had a documented negative HIV antibody test within the past year before the tuberculosis diagnosis; choose Not Offered if the patient was not offered an HIV test at the time of the tuberculosis diagnostic evaluation; choose Positive if the patient was tested for HIV and the laboratory result is interpreted as positive; choose Refused if the patient was offered an HIV test at the time of the tuberculosis diagnostic evaluation, but declined to be tested; choose Test Done/Results Unknown if the patient has been tested and the results are not known; choose Unknown if it is not known if the patient has had an HIV antibody test or was offered a test. Code O
Unknown
Test Done, Results Unknown
Positive
Procedure refused
Negative
Not offered
Indeterminate		 HIV Status

Observation/OBX Segment with this UID and label CWE O [0..1]
TB123 HIV Based On If a value of Positive is specified for HIV Status, indicate the basis for the value entered (patient history, medical documentation, or unknown). Code O
Chart evaluation, medical records perspective
History taking
Unknown		 HIV Diagnosis Based On

Observation/OBX Segment with this UID and label CWE O [0..1]
TB124 CDC AIDS Patient Number If a value of Positive is specified for HIV Status, enter the CDC AIDS patient number (if AIDS is reported prior to 1993). Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB125 State AIDS Patient Number If a value of Positive is specified for HIV Status, enter the state HIV/AIDS patient number (if AIDS is reported in 1993 or later). Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB126 City County AIDS Patient Number If a value of Positive is specified for HIV Status, enter the city or county HIV/AIDS patient number (if AIDS is reported in 1993 or later). Text O




Observation/OBX Segment with this UID and label ST O [0..1]
TB127 Homeless Within Past Year Indicate whether the patient was homeless at any time during the 12 months preceding the tuberculosis diagnostic evaluation. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB128 Resident of Correctional Facility at Time of Diagnosis Indicate whether the patient was a resident of a correctional facility at the time the tuberculosis diagnostic evaluation was performed. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB129 Type of Correctional Facility If a value of Yes is specified for Resident of Correctional Facility at Time of Diagnosis, indicate the type of correctional facility. Code O
Unknown
State Prison
Juvenile Correctional Facility
Federal Prison
Local Jail
Other Correctional Facility 		Type of Correctional Facility

Observation/OBX Segment with this UID and label CWE O [0..1]
TB130 Resident of Long Term Care Facility at Time of Diagnosis Indicate whether the patient was a resident of a long term care facility at the time the tuberculosis diagnostic evaluation was performed. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB131 Type of Long Term Care Facility If a value of Yes is specified for Resident of Long Term Care Facility at time of Diagnosis, indicate the type of long term care facility Code O
Alcohol or Drug Treatment Facility
Hospital-Based Facility
Residential Facility
Long term care hospital
Nursing home
Psychiatric hospital		 Type of Long Term Care Facility

Observation/OBX Segment with this UID and label CWE O [0..1]
TB132 Isoniazid therapy Isoniazid therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB133 Rifampin therapy Rifampin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB134 Pyrazinamide therapy Pyrazinamide therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB135 Ethambutol therapy Ethambutol therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB136 Streptomycin therapy Streptomycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB137 Ethionamide therapy Ethionamide therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB138 Kanamycin therapy Kanamycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB139 Cycloserine therapy Cycloserine therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB140 Capreomycin therapy Capreomycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB141 Para-Amino Salicylic Acid therapy Para-Amino Salicylic Acid therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB142 Amikacin therapy Amikacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB143 Rifabutin therapy Rifabutin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB144 Ciprofloxacin therapy Ciprofloxacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB145 Ofloxacin therapy Ofloxacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB146 Other initial regimen Other initial regimen: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if there is no other drug known to be part of the initial regimen; choose Unknown if it is not known whether another drug is part of the initial regimen; choose Yes if it is known that an drug not already listed is part of the initial regimen. Code O
Yes
No
Unknown		 Yes No Unknown (YNU) IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response.
Observation/OBX Segment with this UID and label CWE O [0..1]
TB147 Date Therapy Started Date on which the patient began therapy for tuberculosis (or suspected tuberculosis). This date may be derived from: the date the patient first ingested medication (if documented in a medical record or directly observed therapy record); the date medication was first dispensed to the patient (as documented in a medical or pharmacy record); the date medication was first prescribed to patient by a health care provider (documented in a medical record or prescription given to the patient) Date O


Validate that the Date Therapy Started is equal to or before stop therapy date; Validate that if the Date Therapy Started has a value then the value for DOT Weeks must not be greater than the number of weeks between Date Therapy Started and Stop Therapy Date; IF Initial Drug Regimen has at least one drug with a value of "Yes" [drug selected in the initial drug regimen] then enableDate Therapy Started;
Observation/OBX Segment with this UID and label TS O [0..1]
TB148 Injecting Drug Use Within Past Year Indicate whether the patient has injected drugs within the past year (use of a syringe for injecting drugs not prescribed by a physician); No if it is known that the patient has not injected drugs within the past 12 months; Unknown if it is not known whether or not the patient has injected drugs within the past 12 months; Yes if it is known that the patient has injected drugs within the past 12 months. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB149 Non-Injecting Drug Use Within Past Year Indicate whether the patient has used non-injected drugs within the past year (drugs not prescribed by a physician); No if it is known that the patient has not used non-injected drugs within the past 12 months; Unknown if it is not known whether or not the patient has used non-injected drugs within the past 12 months; Yes if it is known that the patient has used non-injected drugs within the past 12 months. Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB150 Excess Alcohol Use Within Past Year Indicate whether the patient engaged in excessive use of alcohol within the past year; No if it is known that the patient did not use alcohol to excess within the past 12 months; Unknown if it is not known whether the patient used alcohol to excess within the past 12 months; choose Yes if it is known that the patient used alcohol to excess within the past 12 months Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB151 Employment Status Patient’s Employment Status: Unknown if the employment history of the patient during the 24 months preceding the tuberculosis diagnostic evaluation is not known; Not Employed if the patient was not employed during the entire 24 months preceding the tuberculosis diagnostic evaluation; Employed if the patient was employed for some part of the 24 months preceding the tuberculosis diagnostic evaluation. Code O
Employed
Unemployed
Unknown		 Employment Status

Observation/OBX Segment with this UID and label CWE O [0..1]
TB152 Occupation Risk Category Occupation Risk Category. This is a derived field: If OCCUPATION_HEALTH_CARE_INDICATOR (FC783) = TRUE, then set to 'Health Care Worker'. If OCCUPATION_MIGRATORY_AG_INDICATOR (FC785) = TRUE, then set to 'Migratory Agricultural Worker'. If OCCUPATION_CORRECTIONAL_INDICATOR (FC784) = TRUE, then set to 'Correctional Employee'. If OCCUPATION_OTHER_INDICATOR (FC786) = TRUE, then set to 'Other Occupation'. Code O Y Health Care Worker
Migratory Agricultural Worker
Correctional Facility Employee
Other Occupation 		Occupation Risk Category (TB)

Observation/OBX Segment with this UID and label CWE O [0..*]
TB153 Count at CDC as verified Yes if the case is to be counted as verified at CDC. Code R
True
False		 Yes No Indicator (HL7) If Vercount = "Yes", then the Month/Year counted and MMWR Reporting Date are required;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB154 Case Verification Initially, the value selected in this list is based on data entered earlier across the course of the case and the default value is the most applicable case verification result based on the data supplied; the default value may be overridden as appropriate; the values that appear in this list can vary from one case to the next as the list is dynamically composed based on the factors: culture results, smear results, major and additional sites of the disease, x-ray results, TST, IDR, reason therapy was stopped. The values for this field include: • 0 - Not a Verified Case: choose if the case is not a verified case of tuberculosis; • 1 - Positive Culture: choose if the case is a verified case, based on a positive sputum culture result; • 2 - Positive Smear/Tissue: choose if the case is a verified case, based on a positive sputum smear result and/or tissue (or fluid) exam; • 3A - Clinical Case Definition - PULM: choose if the case is a verified case, based on pulmonary conditions; • 3B - Clinical Case Definition - Extra-PULM: choose if the case is a verified case, based on extra-pulmonary conditions; • 4 - Verified by Provider Diagnosis: choose if the case is a verified case, based on healthcare provider diagnosis; • 5 - Suspect: choose if the case is not verified, but the healthcare provider suspects the case to be one of tuberculosis. Code R
0 - Not a Verified Case
1 – Positive Culture
5 – Suspect
3B – Clinical Case Definition – Extra-PULM
3A – Clinical Case Definition – PULM
4 - Verified by Provider Diagnosis
2 – Positive Smear/Tissue		 Case Verification (TB) If VERCRIT is 1, 2, 3, or 4, display the count date question; IF [Sputum Smear (17) = 'Positive' OR Microscopic Exam of Tissue and Other Body Fluids (19) = 'Positive'] AND [Sputum Culture (18) = 'Not Done' or 'Unknown' AND Culture of Tissue and Other Body Fluids (20) = 'Not Done' or Unknown] THEN Case Verification (VERCRIT) = 2 - Positive Smear/Tissue.; IF [Major Site (15) or Additional Site (16) = 'Pulmonary' and/or 'Pleural' and/or 'Lymph: Intrathoracic'] AND [Sputum Culture (18) <> 'Positive' AND Culture of Tissue and Other Body Fluids (20) <> 'Positive'] AND [Tuberculin Skin Test at Diagnosis (22) = 'Positive'] AND [Initial Drug Regimen (27) at least two of the listed medications = 'Yes'] AND [{X-Ray (21A) = 'Abnormal'} AND {X-Ray Condition (21B) = 'Cavitary' or 'Non-Cavitary Like TB'} AND {X-Ray Stability (21C) = 'Worsening' or 'Improving'}] THEN Case Verification (VERCRIT) = 3A - Clinical Case Definition - PULM.; IF [Major Site (15) or Additional Site (16) = 'Lymphatic Cervical', 'Lymphatic Other', 'Lymphatic Unknown', 'Bone and/or Joing', 'Genitourinary', 'Miliary', 'Memingeal', 'Peritoneal', 'Site Not Stated', or 'Other'] AND [Sputum Culture (18) <> 'Positive' AND Culture of Tissue and Other Body Fluids (20) <> 'Positive'] AND [Tuberculin Skin Test at Diagnosis (22) = 'Positive'] AND [Initial Drug Regimen (27) at least two of the listed medications = 'Yes'] THEN Case Verification (VERCRIT) = 3B - Clinical Case Definition - Extra-PULM.; IF Case Verification (VERCRIT) <> '1 - Positive Culture' OR '2 - Positive Smear/Tissue' OR '3A - Clinical Case Definition - PULM' OR '3B - Clinical Case Definition - Extra-PULM' THEN Case Verification (VERCRIT) = 5 - Suspect.; If Case Verification (VERCRIT) = '5 - Suspect' THEN the user may only change the Case Verification to either '4 - Verified by Provider Diagnosis' or '0 - Not TB' ; FC123: SHALL NOT allow RVCTS with automatically calculated (based on specific RVCT question values) VERCRITS = "0 - Not a Verified Case", "1-Positive Culture", "2-Positive Smear/Tissue", or "3-Clinical Case Definition" to be changed to any other VERCRIT value.; FC124: SHALL allow RVCTs with VERCRITS = "5 - Suspect" to be changed to "4 - Verified by Provider" or "0-Not TB" OR RVCTs with VERCRITS = "4 - Verified by Provider" to be changed to "5 - Suspect" or "0 - Not TB" OR RVCTs with VERCRITS = "0 - Not TB" to be changed to "5 - Suspect" or "4 - Verified by Provider".
Observation/OBX Segment with this UID and label CWE O [0..1]
TB156 Was Drug Susceptibility Testing Done Indicate whether a drug susceptibility test was performed; No if no drug susceptibility test was performed; Unknown whether drug susceptibility testing was performed; Yes if the patient has any isolate upon which drug susceptibility testing was performed Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB157 Date First Isolate Collected If a value of Yes is specified for Was Drug Susceptibility Testing Done, collection date of the first isolate on which drug susceptibility was performed. Date O


Validate that the Initial susceptibility test date is at least 30 days before Final susceptibility test date; Validate that the Patient Date of Birth is equal to or before Initial Susceptibility test date; Validate that the Date Entered U.S. is equal to or before initial susceptibility test date; Validate that the Previous TB Year is greater than 12 months before Initial Susceptibility test date
Observation/OBX Segment with this UID and label TS O [0..1]
TB158 Isoniazid initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Isoniazid: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB159 Rifampin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Rifampin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB160 Pyrazinamide initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Pyrazinamide: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB161 Ethambutol initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ethambutol: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB162 Streptomycin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Streptomycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB163 Ethionamide initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed forEthionamide: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB164 Kanamycin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Kanamycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB165 Cycloserine initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Cycloserine: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB166 Capreomycin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Capreomycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB167 Para-Amino Salicylic Acid initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Para-Amino Salicylic Acid: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB168 Amikacin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Amikacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB169 Rifabutin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Rifabutin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB170 Ciprofloxacin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ciprofloxacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB171 Ofloxacin initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ofloxacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB172 Other initial susceptibility Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for the other initial therapy drug: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. Code O
Resistant
Susceptible		 Susceptibility Result IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section
Observation/OBX Segment with this UID and label CWE O [0..1]
TB173 Culture Conversion Documented Indicate whether the sputum culture conversion was documented; No if the patient had an initially positive sputum culture and no subsequent consistently negative cultures; Unknown if the results of all follow-up cultures are unknown or if it is not known whether follow-up cultures were obtained; Yes if the patient had an initially positive sputum culture followed by one or more consistently negative cultures Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB174 Date of Initial Positive Culture Date the initially positive sputum culture was collected. Date O


Validate that the Patient Date of Birth is equal to or before First positive culture date; Validate that the Date Entered U.S. is equal to or before first positive culture date; Validate that the Previous TB Year. is greater than 12 months before First positive culture date; Validate that the First positive culture date is before First negative culture date;
Observation/OBX Segment with this UID and label TS O [0..1]
TB175 Date of First Consistently Negative Culture Date the first consistently negative sputum culture was collected. Date O


Validate that the Patient Date of Birth is equal to or before First negative culture date;Validate that the Date Entered U.S. is equal to or before first negative culture date; Validate that if First Negative culture date has a date then first positive culture date has a date; Validate that the First negative culture date is more than 12 months after previous TB year; Validate that the First Negative Culture Date must be after First Positive Culture Date;
Observation/OBX Segment with this UID and label TS O [0..1]
TB176 Date Therapy Stopped Date the patient stopped taking therapy for verified or suspected tuberculosis; this date is one of the following (in order of preference): • Date that the patient last ingested medication; • Date the medication dispensed to the patient would have run out, if the patient had taken all of the medication; • Date the medication prescribed to the patient would have run out, if the patient had taken all of the medication from the date of prescription. Date O




Observation/OBX Segment with this UID and label TS O [0..1]
TB177 Reason Therapy Stopped Primary reason that therapy was ended; specify this data when the case is closed; Completed therapy if the patient successfully completed the prescribed therapy; Moved if the patient moved to another jurisdiction before the treatment was completed; Lost if the patient cannot be located prior to the completion of treatment; Uncooperative or refused if the patient refused to complete therapy (update if the patient resumes therapy); Not TB if the completed diagnostic therapy determined that the diagnosis of tuberculosis was not substantiated; Died if the patient expired before therapy was completed; Other if therapy was discontinued for some other reason; Unknown if the reason for ending therapy is not known. Code O
Lost to Follow-Up/Unable to Locate
Moved
Uncooperative or refused		 Reason Therapy Stopped (TB) IF Reason Therapy Stopped = "Not TB"THEN Case Verification (VERCRIT) = 0 - Not a Verified Case;
Observation/OBX Segment with this UID and label CWE O [0..1]
TB178 Type of Health Care Provider Type of health care provider involved in the care for the patient; Health Department, Private Practice, Both Health Dept and Private/Other, or Unknown are valid concepts. Code O
Both Health Dept and Private/Other
Private Practice
Health Department		 Health Care Practice Type (TB)

Observation/OBX Segment with this UID and label CWE O [0..1] Note that this was formerly marked as "repeating" but the value set has the multiple built as a single concept, so repeating message format not necessary
TB179 Directly Observed Therapy Choose the therapy that was directly observed by the health care provider (directly observed therapy, or DOT): No, Totally Self-Administered if no doses of medication were given under supervision; Unknown if it is not known whether any doses of medication were given under supervision; Yes, Both DOT and Self-Administered if one or more doses of medication were given under supervision and one or more were not; Yes, Totally Directly Supervised if all doses of medication were given under supervision. Code O
No, Totally Self-Administered
Yes, Totally Directly Observed
Yes, Both DOT and Self-Administered		 Directly Observed Therapy (TB)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB180 Sites of Directly Observed Therapy If any medication was administered under DOT conditions, select the site(s) where this occurred; may select one or multiple sites; use Ctrl+Click to select multiple sites; Both in facility and in the field if both were used (for example, the patient received medicine under DOT at a clinic and outside the clinic when the patient did not show up at the clinic); In clinic or other facility if the patient received medicine DOT at a health department or private provider facility; In the field if the patient received medicine under DOT solely outside any facility (for example, at the patient's home or workplace); Unknown if the DOT sites are not known Code O
Both in facility and in the field
In clinic or other facility
In the field		 Sites of Directly Observed Therapy (TB)

Observation/OBX Segment with this UID and label CWE O [0..1] Note that this was formerly marked as "repeating" but the value set has the multiple built as a single concept, so repeating message format not necessary
TB181 Number Weeks Directly Observed Therapy Number of weeks of directly observed therapy (DOT); enter the total number of calendar weeks (Sunday through Saturday) that the patient received the minimum amounts of medication under DOT conditions; the number of weeks entered must be less than the number of weeks between 28. Date Therapy Started and 36. Date Therapy Stopped; If the patient was on a twice-weekly regimen: count a week only if both of the week's doses were given under DOT; If the patient was on a three-times-weekly regimen: count a week only if all three of the week's doses were given under DOT; If the patient was on a daily regimen: count a week only if five or more of the week's doses were given under DOT; If the patient was on a daily regimen: count a week only if five or more of the week's doses were given under DOT; If the patient did not receive the minimum number of doses under DOT, do not count the week. Numeric O




Observation/OBX Segment with this UID and label SN O [0..1]
TB182 Follow-Up Susceptibility Testing Indicate whether final drug susceptibility was performed; No if no final drug susceptibility testing was performed; Yes if drug susceptibility testing was performed on an isolate that was collected ³30 days after the isolate for which the initial drug susceptibility testing was done; Unknown if it is not known whether follow-up drug susceptibility testing was done Code O
Yes
No
Unknown		 Yes No Unknown (YNU)

Observation/OBX Segment with this UID and label CWE O [0..1]
TB183 Follow-Up Susceptibility Testing Date If a value of Yes is specified for Was Follow-up Susceptibility Testing Done, indicate the date on which this testing was done Date O


Validate that the Patient Date of Birth is equal to or before Final Susceptibility Test date; Validate that the Date Entered U.S. is equal to or before Final Susceptibility test date
Observation/OBX Segment with this UID and label TS O [0..1]
TB184 Isoniazid final susceptibility If follow-up susceptibility testing was done, results of the testing for Isoniazid: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB185 Rifampin final susceptibility If follow-up susceptibility testing was done, results of the testing for Rifampin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB186 Pyrazinamide final susceptibility If follow-up susceptibility testing was done, results of the testing for Pyrazinamide: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB187 Ethambutol final susceptibility If follow-up susceptibility testing was done, results of the testing for Ethambutol: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB188 Streptomycin final susceptibility If follow-up susceptibility testing was done, results of the testing for Streptomycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB189 Ethionamide final susceptibility If follow-up susceptibility testing was done, results of the testing for Ethionamide: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB190 Kanamycin final susceptibility If follow-up susceptibility testing was done, results of the testing for Kanamycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB191 Cycloserine final susceptibility If follow-up susceptibility testing was done, results of the testing for Cycloserine: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB192 Capreomycin final susceptibility If follow-up susceptibility testing was done, results of the testing for Capreomycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB193 Para-Amino Salicylic Acid final susceptibility If follow-up susceptibility testing was done, results of the testing for Para-Amino Salicylic Acid: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB194 Amikacin final susceptibility If follow-up susceptibility testing was done, results of the testing for Amikacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB195 Rifabutin final susceptibility If follow-up susceptibility testing was done, results of the testing for Rifabutin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB196 Ciprofloxacin final susceptibility If follow-up susceptibility testing was done, results of the testing for Ciprofloxacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB197 Ofloxacin final susceptibility If follow-up susceptibility testing was done, results of the testing for Ofloxacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]
TB198 Other final susceptibility If follow-up susceptibility testing was done, results of the testing for Other Drugs: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. Code O
Resistant
Susceptible		 Susceptibility Result

Observation/OBX Segment with this UID and label CWE O [0..1]

Sheet 8: Notification Structure
These variables are not negotiable. Default values are provided for HL7 structural elements that are required but not part of the surveillance data requested.





Notification Variables
Mapping Methodology
PHIN Variable ID Label/Short Name Description Data Type CDC Req/Opt May Repeat Coded Concepts Value Set Name Data Validation
Message Context HL7 Data Type HL7 Usage HL7 Cardinality Implementation Notes
NOT108 Notification ID The unique identifier for the notification record. String R




MSH-10-Message Control ID. No UID or label is passed in the message. ST R [1..1] HL7 recommended size increased to 50
DEM197 Local patient ID The local ID of the patient/entity. String R




PID-3.1 Patient Identifier List – ID Number
PID-3.4 Assigning Authority format <localID&OID&ISO>
Does not pass Variable ID or label.		 CX R [1..1] Only the sending system's internally assigned patient id used for these de-identified messages
DEM100 Patient name type Name is not requested by the program, but the Patient Name field is required to be populated for the HL7 message to be valid. Have adopted the HL7 convention for processing a field where the name has been removed for de-identification purposes. Coded R
Pseudonomized name Name Type (HL7)

PID-5.7 Patient Name Type - second instance (does not pass Variable ID or label). HL7 reserves the first instance of the name for Legal Name. XPN R [1..2] Literal value: |~^^^^^^S|
INV168 Local record ID Sending system-assigned local ID of the case investigation with which the subject is associated.(This is the RVCT ID for TB) Text R




OBR-3-Filler Order Number where OBR-3.1 is the internally assigned case/investigation ID, OBR-3.3 is the OID for sending application as assigning authority, and OBR-3.4 is the literal value 'ISO'. The UID and label are not passed in the message. EI R [1..1] <same value in each OBR instance>
NOT099 Subject Type Type of subject for the notification. Coded R

Notification Section Header

OBR|1|: Maps to the HL7 attribute OBR-4-Universal Service ID. No UID or label is passed in the message. CE R [1..1] Literal Value: 'PERSBJ^Person Subject^2.16.840.1.114222.4.5.274'
NOT101 Notification Type Type of notification. Main notification types are "Individual Case", "Environmental", "Summary", and "Laboratory Report". Coded R

Notification Section Header

OBR|2|: Maps to the HL7 attribute OBR-4-Universal Service ID. No UID or label is passed in the message. CE R [1..1] Literal Value: 'NOTF^Case Notification^2.16.840.1.114222.4.5.274'
NOT103 Date First Submitted Date the notification was first sent to CDC. This value does not change after the original notification. Date/time R




Maps to the HL7 attribute OBR-7-Observation Date/time. No UID or label is passed in the message. TS R [1..1] <same value in each OBR instance>
NOT106 Date of Report Date/time this version of the notification was sent. It will be the same value as NOT103 for the original notification. For updates, this is the update/send date/time. Date/time R




Maps to the HL7 attribute OBR-22-Result Report/Status Chg Date/time. No UID or label is passed in the message. TS R [1..1] <same value in each OBR instance>
INV169 Condition Code Condition or event that constitutes the reason the notification is being sent. Coded R

Nationally Notifiable Infectious Disease (NNID) reportable to the Nationally Notifiable Disease Surveillance System (NNDSS)

Maps to HL7 attribute OBR-31-Reason for Study. The UID and label are not passed in the message. CE R [1..1] Default value in each OBR instance: '10220^Tuberculosis^2.16.840.1.1142224.5.78'
File Typeapplication/vnd.ms-excel
Authorzvx6
Last Modified Bywsb2
File Modified2007-09-11
File Created2006-11-07
© 2024 OMB.report | Privacy Policy